JP2007315883A - Latex composition for immunoassay - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide a latex composition for an immunoassay used to perform a high-sensitivity immunoassay with latex particles, obtained by together binding antibodies prevented from agglutinating spontaneously. <P>SOLUTION: This latex composition for an immunoassay comprises latex particles, obtained by binding antibodies or their antigen-binding fragments together, a medium for causing the latex particles to be suspended therein, at least one kind of agglutination preventive agent selected from among a group comprising saccharide and polyvalent alcohol, protein, and a buffer agent. and has a pH of 9.0 to 9.8. The latex particles, obtained by together binding antibodies, are prevented from spontaneously agglutinating to provide the new latex composition for an immunoassay that enables high-sensitivity immunoassays. This composition makes it possible to measure a detecting object in a specimen with high sensitivity and accuracy by a simple measurement method, such as immuno-chromatography that is carried out at medical sites, in particular, since the detection sensitivity can be raised which has been lowered until, now because the specific gravity, viscosity, and osmotic pressure will rise. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

  The present invention relates to a latex composition for immunoassay that is useful as a labeled antibody used for immunochromatography or flow-through immunoassay and a measurement reagent for immunoagglutination.

  In recent years, simple test reagents and kits have been developed that perform various tests such as the presence or absence of pathogens such as viruses and bacteria and the presence or absence of pregnancy within a short time. Pathogen components, human chorionic gonadotropins, and the like are targets for detection or quantification. Many of the simple test reagents have the feature that they do not require special equipment, are easy to operate and are inexpensive, and for example, simple test reagents for pregnancy diagnosis are sold at general pharmacies. Moreover, unlike other test reagents, simple test reagents for testing pathogen infection are widely used in general hospitals and clinics in addition to large hospitals and medical test centers. These facilities are often the first medical institutions visited by patients, and if the presence or absence of infection is identified on the spot for samples collected from patients, treatment can be performed at an early stage. The importance in medicine is increasing.

  Currently, immunoassay using antigen-antibody reaction as a simple test method, in particular, a measurement method using a membrane such as nitrocellulose is generally known, and it is widely used for flow-through type and lateral flow type (also called immunochromatography). Separated. The former allows a solution containing an object to be detected to pass in the vertical direction with respect to the membrane, and the latter allows the solution to be developed in the horizontal direction. In either case, a complex of a capture substance that specifically binds to the analyte and a label that specifically binds to the analyte is formed on the solid phase, and the label is detected or quantified. This is common in that the detection object is detected or quantified. The lateral flow method is being used widely for detection of a wide variety of antigens because it has a simpler measuring device than the flow-through method and is superior in cost.

  Conventionally, antibodies that specifically bind to an object to be detected and bound to gold particles have been widely used as a label, but a measurement system using colored latex particles has been established and the objects to be measured are being further expanded. . In particular, immunoassay by immunochromatography is highly expected because the target pathogenic microorganism antigen can be measured by preparing an antibody.

  However, latex particles to which antibodies are bound tend to spontaneously aggregate. For example, in the case of immunochromatography, latex particles are bound nonspecifically on the membrane or clogged in the membrane. As a result, the detection sensitivity is lowered to increase the background, and it becomes a serious problem because it binds non-specifically to the capture substance and shows a false positive.

  That is, the natural aggregation has a great influence on the detection sensitivity and reduces the S (signal) / N (noise) ratio necessary for the measurement. When evaluating a reagent, it is always necessary that the S / N ratio is large, and the technique of reagentization is a problem of how to increase the S / N ratio and make it constant. The natural agglomeration includes agglomeration that can be dispersed by physical agitation to a strong one that cannot be dispersed by physical agitation. In particular, in the latter case, since it cannot be recovered to the extent that it is stirred at the time of use, the reaction is affected, and the detection sensitivity and specificity are significantly affected.

  Conventionally, amino acids having two or more amino groups in one molecule (Patent Document 1) added for the purpose of preventing spontaneous aggregation are known, but the specific gravity and viscosity are increased, which significantly affects detection sensitivity. There are drawbacks. Further, N, N-dialkylamide, lower alkyl sulfoxide and the like as additives (see Patent Document 2) are disclosed in Patent Document 3 together with chaotropic reagents such as guanidine, guanidine hydrochloride, guanidinium thiocyanate and urea. Alkali metal halides such as lithium, lithium bromide, sodium bromide, potassium bromide and lithium iodide, and metal halides such as calcium chloride are described. Further, methods of adding glycine, choline chloride and the like are also known, but all of them are effective for stabilization to the extent that they are dispersed by physical stirring, but are not effective for strong natural aggregation.

Japanese Patent Publication No. 6-17911 Japanese Patent Laid-Open No. 55-160853 JP 56-158947 A

  Accordingly, an object of the present invention is to provide a latex composition for immunoassay that prevents spontaneous aggregation of latex particles bound with an antibody and enables highly sensitive immunoassay.

  As a result of diligent research, the inventor of the present application has added a specific anti-aggregation agent and protein, and has adjusted the pH of the composition using a basic buffer to a specific range not used in conventional latex compositions. By setting the pH high, the natural aggregation of the latex particles is effectively prevented, and the antigen-antibody reactivity of the antibody does not decrease despite the high pH, which is higher than when a known latex composition is used. The present inventors have found that a sensitive immunoassay can be performed and completed the present invention.

  That is, the present invention comprises latex particles to which an antibody or antigen-binding fragment thereof is bound, a medium for suspending the latex particles, at least one aggregation inhibitor selected from the group consisting of sugars and polyhydric alcohols, Provided is a latex composition for immunoassay comprising a protein and a buffer and having a pH of 9.0 to 9.8.

  INDUSTRIAL APPLICABILITY According to the present invention, there has been provided a novel latex composition for immunoassay that prevents spontaneous aggregation of antibody-bound latex particles and enables highly sensitive immunoassay. According to the composition of the present invention, it is possible to increase the detection sensitivity, which has been lowered due to the increase in specific gravity, viscosity and osmotic pressure. An object to be detected can be measured with high sensitivity and accuracy.

Latex particles contained in the composition of the present invention may be the same as latex particles that have been widely used for immunoassay, and may be polystyrene, styrene-butadiene copolymer,
A styrene-styrene sulfonate copolymer or the like can be used, and various products are commercially available. When used as a labeled antibody in immunochromatography or flow-through immunoassay, colored latex particles are preferred. In addition, the antibody or antigen-binding fragment thereof described later may be physically adsorbed on the latex particle, but in order to bind more stably or in large quantities, it is preferable to bind to the latex particle by a covalent bond. For such purposes, those having functional groups such as carboxyl groups on latex particles can be preferably used. Colored latex particles and latex particles having a functional group such as a carboxyl group are also commercially available, and commercially available products can be preferably used. The diameter of the latex particles is not particularly limited, but is usually about 0.1 μm to 0.8 μm, preferably about 0.2 μm to 0.6 μm.

  Antibodies or antigen-binding fragments thereof are bound on the latex particles. The antibody is an antibody that undergoes an antigen-antibody reaction with a detection target to be immunoassay, and may be a polyclonal antibody or a monoclonal antibody. Here, the substance to be detected is not limited at all, and may be any substance capable of antigen-antibody reaction with an antibody such as various pathogens and various clinical markers. As specific examples, virus antigens such as influenza virus, adenovirus, RS virus, HAV, HBs, HIV, nor Oak-like virus, MRSA, group A streptococcus, group B streptococcus, bacterial antigens such as Legionella spp. Toxins, mycoplasmas, Chlamydia trachomatis, hormones such as human chorionic gonadotropin, C-reactive protein, myoglobin, cardiac troponin, various tumor markers, pesticides, environmental hormones, etc. It is not a thing.

Instead of the antibody or together with the antibody, the antigen-binding fragment of the antibody may be bound to the latex particles. An antigen-binding fragment is a fragment capable of antigen-antibody reaction with a corresponding antigen, such as an antibody Fab or F (ab ′) ₂ fragment. These antigen-binding fragments can be obtained by treating an antibody with a proteolytic enzyme such as papain or pepsin, as is well known. In addition, an antibody produced by genetic engineering or an antigen-binding fragment thereof can be used.

  The antibody or antigen-binding fragment thereof can be bound to latex particles by a well-known method, and can be bound by physical adsorption or covalent bond. As described above, for example, latex particles having a carboxyl group on the surface are commercially available. By binding this carboxyl group to the amino group of the antibody or antigen-binding fragment thereof, the antibody or antigen-binding fragment thereof can be covalently bound. Can bind to latex particles. The amount of the antibody or antigen-binding fragment thereof that binds to the latex particles is not particularly limited and may be the same as in the past, and varies depending on the particle size, but is usually about 10 to 100 μg per 1 mg of the particles.

  The content of latex particles to which the antibody or antigen-binding fragment thereof is bound is not particularly limited, but is usually about 0.005 w / v% to 0.2 w / v%, preferably 0.01 w / v% to 0.1. It is about w / v%.

  As a medium for suspending latex particles, water (including an aqueous solution) is usually used.

  The latex composition of the present invention contains at least one aggregation inhibitor selected from the group consisting of sugars and polyhydric alcohols. As specifically described in the examples below, by containing this anti-agglomeration agent, the natural aggregation of latex particles is suppressed as compared to the case where it is not included.

  As the saccharide, monosaccharides and oligosaccharides (having 2 to 6 monosaccharides) and sugar alcohols thereof are preferable, and monosaccharides and disaccharides and sugar alcohols thereof are particularly preferable. Preferable specific examples include, but are not limited to, saccharose, trehalose, maltose, lactose, sorbitol and D-mannitol. The polyhydric alcohol is a compound having a plurality of alcoholic hydroxyl groups in one molecule, and has about 2 to 10 carbon atoms, particularly those having 2 to 4 carbon atoms, particularly a linear or branched chain polyhydric alcohol. Is preferred. In particular, glycerin, which is a trivalent alcohol, and polyvinyl alcohol, which is a water-soluble polyhydric alcohol, are preferable. In particular, glycerin is particularly preferable because an effect of enhancing the stability of antibody protein can be easily obtained.

  In the case of immunochromatography, a label (antibody-bound latex particles) obtained by labeling latex particles with an antibody is often applied to a pad and dried. Glycerin is difficult to dry at room temperature. On the other hand, the saccharide has an effect as a stabilizer of the latex composition when dried. Therefore, in such a case, it is preferable to use saccharides rather than glycerin.

  The concentration of the anti-aggregation agent in the latex composition (when multiple types of anti-agglomeration agents are included, the total concentration) takes into consideration the type of detection object, the required detection sensitivity, the measurement system used, etc. Although it may be appropriately selected, it is generally preferably 3 to 20 w / v%. If the concentration is less than 3 w / v%, the effect is low, and if the concentration exceeds 20 w / v%, the protective effect of natural aggregation increases, but conversely, the detection sensitivity of the immunoassay may decrease.

  Furthermore, the latex composition of the present invention contains a protein. The protein referred to in the present invention is a protein that has been added to a conventional immunoassay reagent as a stabilizer, nonspecific reaction inhibitor, blocking agent, etc., and does not bind to an object to be detected. Although not particularly limited, albumin (bovine serum albumin, egg-derived albumin, etc.), casein, gelatin, normal immunoglobulin and the like can be preferably used. These proteins can be used alone or in combination of two or more. The concentration of these proteins in the latex composition (when multiple types are included, the total concentration thereof) is preferably 0.02 to 0.1 w / v%, more preferably 0.04 to 0.08 w / v. %. If the concentration is less than 0.02 w / v%, the natural aggregation may become stronger as the concentration decreases, and if it exceeds 0.1 w / v%, the natural aggregation may become stronger as the concentration increases.

  The pH of the latex composition of the present invention is 9.0 to 9.8, preferably 9.2 to 9.6. As specifically shown in the examples below, the pH of the composition plays an important role in preventing spontaneous aggregation of latex particles. That is, when the pH is less than 9.0, the natural aggregation becomes strong, whereas when it exceeds 9.8, the antibody gradually changes in quality and spontaneous aggregation occurs. The pH of a conventional latex composition for immunoassay is generally about neutral to weakly basic pH 7.0 to 8.0, and the pH of the composition of the present invention is higher than the pH of the conventional latex composition. Surprisingly, by adopting this high specific range of pH, the natural agglomeration of the latex is more effectively suppressed. This is considered that the dispersion stability of latex particles was improved by high pH. In addition, when such a high pH is adopted, it is considered that the antibody or antigen-binding fragment thereof bound to latex particles is denatured and the antigen-antibody reactivity is lowered. In the presence of the protein, the antigen-antibody reactivity of the antibody or antigen-binding fragment thereof does not substantially decrease, and highly sensitive immunoassay is possible as specifically described in the following examples.

  In order to obtain a latex composition having a high pH as described above, an alkaline buffer is preferable as the buffer, and a compound selected from tris base, glycinamide, and arginine is preferable, and the concentration is preferably 2 to 2. It is preferably 8 mM, more preferably 4 to 6 mM. If the concentration is less than 2 mM, spontaneous aggregation may increase as the concentration decreases, and if it exceeds 8 mM, spontaneous aggregation may increase as the concentration increases. Here, the “buffer agent” means a compound that gives a buffer solution when dissolved in water, and the buffer solution includes a buffer agent. The “alkaline buffer” means a buffer that gives an alkaline buffer when dissolved in water. In order to adjust the pH of the latex composition of the present invention to a set value, sodium hydroxide or hydrochloric acid is preferably used, but the present invention is not limited to this.

  The latex composition of the present invention has an effect of preventing spontaneous aggregation, but it can be used by adding surfactants, preservatives and the like conventionally used according to the purpose of use. . The addition amount of the surfactant is preferably in the range of 0.01 to 2 w / v%. As the surfactant, for example, the following can be used. Polyethylene glycol mono-p-isooctylphenyl ether, polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monooleate, nonidet P-40 (trade name), n-tetradecyl-N, N-dimethyl-3-ammonio- 1-propanesulfonate or the like or a mixture of two or more of these can be used, but is not limited thereto.

  Examples of the preservative include, but are not limited to, sodium azide, paraoxybenzoic acid ester, caisson CG (trade name) of isothiazolinones. The concentration of the preservative in the composition (when multiple types are included, the total concentration thereof) is usually about 0.02 to 0.2 w / v%.

  The method of using the latex composition of the present invention is exactly the same as the method of using the conventional latex composition. That is, in the case of immunoassay by the agglutination method, the degree of agglutination of latex particles caused by mixing and reacting the specimen sample and the latex composition suspended / extracted in the specimen suspension / extraction buffer. Is measured by observation with the naked eye, or by photometry using a dedicated analytical instrument. More specific measurement methods include a slide method using a flat plate, a plate method using a microplate, and an automatic analysis method using a dedicated analyzer. The latex particles in the latex composition of the present invention can be used as a labeled antibody for flow-through immunoassay, immunochromatography and the like, and can be used particularly suitably in immunochromatography. When used as a labeled antibody, the latex particles are preferably colored as described above. When used as a labeled antibody, the method of use is exactly the same as that of a conventional latex labeled antibody.

  In the case of immunochromatography using colored latex, a detection part in which an antibody that specifically binds to the detection target is immobilized on a membrane strip, and a label part including a label that specifically binds to the detection target are provided. A sample sample containing an object to be detected is developed on an assay device provided to develop the analyte-label complex, and the label is detected or quantified by capturing the complex with a detection unit. A schematic diagram of a specific example of an immunochromatography apparatus using colored latex particles for labeling is shown in FIG. An upper view of FIG. A specimen sample is prepared by suspending / extracting the specimen in a specimen suspension / extraction buffer. A labeled body portion comprising, in a dry state, a labeled body in which an antibody that specifically binds to an object to be detected or an antigen-binding fragment thereof is labeled with colored latex particles on a membrane (b) laminated on a plastic plate (f) (B) and a sample sample dropping part (d) of the assay device further comprising a detection part (c) in which a capture antibody that specifically binds to the object to be detected and captures the object is bound in a line. The specimen sample is dropped. The specimen sample containing the detection object develops the label while moving on the membrane in the horizontal direction. Therefore, if the detection object exists, a complex of the detection object and the label is formed, and the detection unit ( C), a capture antibody-detected substance-labeled complex is formed on the line, and the presence of the complex is detected by the colored latex particles in the complex to detect the detected substance in the sample. Determine the presence or absence of objects. The detection unit (c) is an antibody or antigen-binding property thereof capable of antigen-antibody reaction with the detected substance and binding to the detected substance simultaneously with the antibody on the latex particle or antigen-binding fragment thereof. This is a region where fragments are immobilized in a line. Other components that are not involved in the reaction are absorbed by the absorbent pad portion (e). In the example shown in FIG. 1, there are two detection units (C). This is because, for example, as described in the following examples, two detection targets such as influenza A virus and influenza B virus are used. This is for capturing each detected object. By providing a plurality of such detection units (c), it is possible to perform immunoassay on a plurality of types of detection objects at the same time. By using the immunochromatography apparatus as described above, which incorporates the latex composition of the present invention containing latex particles in which antibodies or antigen-binding fragments thereof are bound to colored latex particles, the analyte can be measured simply, quickly and with high sensitivity. it can.

  Hereinafter, the present invention will be described more specifically based on examples. However, the present invention is not limited to the following examples.

Example 1
Detection of influenza virus antigens by immunochromatography Preparation of anti-influenza virus monoclonal antibody (1) Anti-influenza A virus NP antibody BALB / c mice were immunized with influenza A virus antigens, and the spleen was removed from mice reared for a certain period of time, and the method of Keller et al. , Nature, vol, 256, p495-497 (1975)) and fused with mouse myeloma cells (P3 × 63). The obtained fused cells (hybridoma) were maintained in a 37 ° C. incubator, and cell purification was performed while confirming the antibody activity of the supernatant by ELISA using a plate on which influenza A virus NP antigen was immobilized (monocloning) ) The obtained two cell lines were each intraperitoneally administered to pristane-treated BALB / c mice, and about 2 weeks later, antibody-containing ascites was collected. IgG was purified from the obtained ascites by affinity chromatography using a protein A column to obtain two types of purified anti-influenza A virus NP antibodies.

(2) Anti-B influenza virus NP antibody Two types of purified anti-B influenza virus NP antibodies were obtained in the same manner as in (1) using influenza B virus antigen.

2. Preparation of labeled body pad One of each of a purified anti-influenza A virus NP antibody and a purified anti-influenza B virus NP antibody was used. Anti-influenza A virus antibody was covalently bound to blue latex particles (CM / BL Ceradyne) having a particle size of 0.394 μm, tris base 5 mM, bovine serum albumin 0.04 w / v%, trehalose 10 w / v% and Triton X-100 (Product name) Prepare solutions of pH 8.8 to 9.8 containing 0.2 w / v%, suspend in these solutions so that the concentration of latex particles is 0.018 w / v%, and perform sonication sufficiently. A dispersion-suspended anti-A type latex suspension was prepared. Similarly, an anti-B type latex suspension liquid to which an anti-type B influenza virus antibody was covalently bound was prepared. Mix anti-A type latex suspension and anti-B type latex suspension at each pH, and apply 50μL per square centimeter to 20cmx1cm glass fiber (33GLASS NO.10539766 Schleicher & Schuell). Then, it was dried well under reduced pressure to prepare a label (pad). The covalent binding of the anti-influenza virus antibody to the latex particles is performed by a one-step method using water-soluble carbodiimide (EDAC) described in Particle Technology RECOMMENDED ADSORPTION and COVALENT COUPLING PROCEDURES 5/13/96 issued by Ceradyne. went.

3. Production of Influenza Virus Detection Assay (Immuno Chromatography) Apparatus An influenza virus detection assay apparatus having the same configuration as that shown in FIG. 1 was used. Nitrocellulose membrane (Hiflow Plus HF120 made by Millipore) is cut to 3cmx20cm size and backed with a plastic plate with adhesive. Anti-A influenza is about 1mm wide at 1.0cm and 1.5cm positions from the bottom edge. 20 cm each of a virus antibody (another antibody) solution and an anti-type B influenza virus antibody (another antibody) solution were applied and dried under reduced pressure to immobilize the antibody (detection part). Next, a filter paper having a size of 3 cm × 20 cm (WF1.5 manufactured by Whatman) was placed 8 mm on the upper end of the nitrocellulose membrane to provide an absorbent pad portion. In addition, a marker pad is placed 2 mm on the bottom of the nitrocellulose membrane to provide a marker body, and a glass fiber (F075-14, manufactured by Whatman) with a size of 2.0 cm x 20 cm is located 3 mm away from the top of the marker pad. And a specimen sample dropping part was provided. Next, an integrated assay device was prepared by cutting into a strip having a width of 5 mm with a cutter.

4). As test specimens, influenza A virus A / Panama / 2007/99 (H3N2) and influenza B virus B / Shangdong / 7/97 cultured in hatched chicken eggs were used. Samples are sample suspension / extraction buffer (50 mM Tris buffer, pH 8.0, Triton X-100 (trade name) 1 (w / v)%, bovine serum albumin 1 (w / v)%, normal immunoglobulin (Mouse) 0.1 (w / v)% and sodium azide 0.09 (w / v)%) were used to prepare the following dilution series as specimen samples.
1: 1 × 10 ³
1: 2 × 10 ³
1: 4 × 10 ³
1: 6 × 10 ³
1: 8 × 10 ³

The specimen suspension / extraction buffer was used as a negative control sample (virus negative). Next, the assay device was placed horizontally, and 100 μL of the specimen sample and the negative control sample were dropped onto the specimen sample dropping portion to develop the label. The determination was made by visually observing the presence or absence of a colored line in the detection part (type A influenza virus detection part and type B influenza virus detection part) after 15 minutes.
With coloring line: Positive (+)
No coloring line: Negative (-)

5). Results The results obtained are shown in Table 1 (Table 1-1 and Table 1-2). As shown in Table 1-1, the sample sample A / Panama is positive for the A type detection part up to 1: 4x10 ³ dilution at pH 9.0 to 9.8, the B type detection part is negative, and the negative control sample is , A type detection part and B type detection part are negative and specifically detect type A influenza virus. However, at pH 8.8, up to 1: 2x10 ^{3 to} 6xx10 ³ dilutions, both the A-type detection unit and the B-type detection unit were positive, and the negative control sample was both positive for the A-type detection unit and the B-type detection unit. It was.

Specimen sample B / Shangdong, as shown in Table 1-2, has a positive B-type detection part up to 1: 2x10 ³ dilution at pH 9.0 to 9.8, negative A-type detection part, negative control sample is In addition, the type A detection part and the type B detection part are both negative and specifically detect the type B influenza virus. However, at pH 8.8, the A type detection part and the B type detection part were both positive from 1: 1x10 ^{3 to} 4x10 ³ dilution, and the negative control sample was also positive for both the A type detection part and the B type detection part, and non-specific reaction was observed. It was. The phenomenon that both the type A detection part and the type B detection part at pH 8.8 using the diluted type A / B influenza virus samples and the negative control sample are positive is due to non-specific binding to the detection line due to spontaneous aggregation of latex particles. It is thought to be due to. From the above results, it is understood that the latex composition has a pH range of 9.0 or more and 9.8 or less.

Example 2
Using the assay device equipped with a pH 9.4 labeled pad used in Example 1, the number of specimens was increased and the detection sensitivity of the method of the present invention and the comparative example was tested.

As test specimens, cultured in hatched chicken eggs,
3 strains of influenza A virus
A / New Caledonia / 20/99 (H1N1)
A / Panama / 2007/99 (H3N2)
A / Beijing / 32/92 (H3N2)
3 strains of influenza B virus,
B / Shangdong / 7/97
B / Johannesburg / 5/99
B / Shanhai / 361/2002
Was used.

  The sample was diluted in the same manner as in Example 1 to prepare a sample sample. 100 μL of the specimen sample was dropped on the specimen sample dropping portion to develop the label.

The determination was made by visually observing the presence or absence of a colored line in the detection part after 15 minutes. The terminal dilution factor determined to be positive was displayed as detection sensitivity.
With coloring line: Positive (+)
No coloring line: Negative (-)

Comparative Example 1
As Comparative Example 1, the detection sensitivity was tested using an in-vitro diagnostic drug and an influenza virus kit “Quick S-Flu A / B“ Seiken ”” (manufactured by Denka Seiken). “Quick S-Flu A / B“ Seiken ”” (manufactured by Denka Seiken) is a flow-through type assay device using a colloidal gold-labeled anti-influenza virus antibody as a label.

Results The results obtained are shown in Table 2. As for the results of the method of the present invention, the virus amount of both type A and type B viruses is smaller than that of Comparative Example 1. It can be seen that the latex composition of the present invention is non-specific and can detect and differentiate influenza A / B influenza viruses with high sensitivity.

検体試料 本発明法 比較例１
Ａ型 Ｂ型 Ａ型 Ｂ型
A/New Caledonia
１：１×１０^３ ＋ − ＋ −
１：２×１０^３ ＋ − − −
１：４×１０^３ ＋ − − −
１：６×１０^３ − − − −

A/Panama
１：１×１０^３ ＋ − ＋ −
１：２×１０^３ ＋ − − −
１：４×１０^３ ＋ − − −
１：６×１０^３ − − − −

A/Beijing
１：２×１０^３ ＋ − ＋ −
１：４×１０^３ ＋ − − −
１：６×１０^３ ＋ − − −
１：８×１０^３ − − − −

B/Shangdong
１：１×１０^３ − ＋ − ＋
１：２×１０^３ − ＋ − −
１：４×１０^３ − − − −
１：６×１０^３ − − − −

B/Johannesburg
１：１×１０^３ − ＋ − ＋
１：２×１０^３ − ＋ − −
１：４×１０^３ − ＋ − −
１：６×１０^３ − − − −

B/Shanhai
１：１×１０^３ − ＋ − ＋
１：２×１０^３ − ＋ − −
１：４×１０^３ − ＋ − −
１：６×１０^３ − − − −

Ａ型：Ａ型インフルエンザウイルス検出部
Ｂ型：Ｂ型インフルエンザウイルス検出部

Specimen Sample Invention Method Comparative Example 1
A type B type A type B type
A / New Caledonia
1: 1 × 10 ³ + − + −
1: 2 × 10 ³ + − − −
1: 4 × 10 ³ + − − −
1: 6 × 10 ³ − − − −

A / Panama
1: 1 × 10 ³ + − + −
1: 2 × 10 ³ + − − −
1: 4 × 10 ³ + − − −
1: 6 × 10 ³ − − − −

A / Beijing
1: 2 × 10 ³ + − + −
1: 4 × 10 ³ + − − −
1: 6 × 10 ³ + − − −
1: 8 × 10 ³ − − − −

B / Shangdong
1: 1 × 10 ³ − + − +
1: 2 × 10 ³ − + − −
1: 4 × 10 ³ − − − −
1: 6 × 10 ³ − − − −

B / Johannesburg
1: 1 × 10 ³ − + − +
1: 2 × 10 ³ − + − −
1: 4 × 10 ³ − + − −
1: 6 × 10 ³ − − − −

B / Shanhai
1: 1 × 10 ³ − + − +
1: 2 × 10 ³ − + − −
1: 4 × 10 ³ − + − −
1: 6 × 10 ³ − − − −

Type A: Influenza A virus detection unit
Type B: Influenza B virus detector

Example 3
The following tests were performed using the same assay device as that prepared in Example 2.

Tests Samples 1 to 10 that were determined to be positive for influenza A virus by PCR and samples 11 to 20 that were determined to be positive for influenza B virus were used from samples wiped from the nasal cavity collected at the test hospital. A sample suspended in 0.3 mL of a sample suspension / extraction buffer (same composition as in Example 1) was used as a sample, and 100 μL thereof was dropped onto the sample sample dropping part. The determination was performed in the same manner as in Example 1.

Results The results obtained are shown in Table 3. The results of the method of the present invention all agreed with the results of the PCR method. As shown in Table 3, it can be seen that the method according to the present invention can specifically detect influenza virus with high sensitivity and simultaneously determine type A / B.

Example 4
F (ab ') ₂ purified fraction (anti-PBP2' purified fraction) by enzymatic treatment of 2 types of monoclonal antibodies against methicillin-resistant Staphylococcus aureus (MRSA) penicillin-binding protein 2 '(PBP2') Got.

  One kind of the anti-PBP2 ′ purified fraction was covalently bound to blue latex particles (CM / BL Ceradine) having a particle size of 0.394 μm in the same manner as in Example 1, and 0.05 w / v% milk casein, 10 w D-mannitol. A solution containing 5% of Tris base and 5 mM Tris base and 0.2 w / v% of Triton X-100 (trade name), pH 9.2 is prepared and suspended so that the concentration of latex particles is 0.018 w / v%. The anti-PBP2 'latex suspension was prepared by sufficient dispersion and suspension.

  A labeled antibody pad was prepared in the same manner as in Example 1. Another type of anti-PBP2 ′ purified fraction was applied to the nitrocellulose membrane at a position corresponding to type A in Example 1 by the same method as in Example 1, and further labeled antibody by the same method as in Example 1. An integrated assay device for detection of PBP2 ′ equipped with a pad was prepared.

PBP2 test Staphylococcus ^aureus, by cultivating Sanseikin (strain 1-5) 5 strain, PBP2 'detection kit "MRSA-LA" Seiken "" by the slide latex agglutination described in the attached documents (Denka Seiken Co., Ltd.) A sample for slide latex agglutination reaction was prepared by the alkali extraction method.

  Using a sample suspension / extraction buffer (same composition as in Example 1), the sample for agglutination reaction is diluted twice to prepare a sample sample. It was dripped.

  The determination was made by visually observing the presence or absence of a colored line in the detection part after 15 minutes. The terminal dilution factor determined to be positive was displayed as detection sensitivity.

Comparative Example 2
As Comparative Example 2, the detection sensitivity was tested by a slide latex agglutination reaction using MRSA-LA “SEIKEN” (manufactured by Denka Seiken Co., Ltd.). The composition of the latex composition used in MRSA-LA “Seiken” (manufactured by Denka Seiken)
Anti-PBP2 'antibody-bound polystyrene particles 0.1 (w / v)%,
Phosphate buffered saline 75 mM, pH 7.0,
Bovine serum albumin 0.5 (w / v)%
Sodium azide 0.08 (w / v)%,
The anti-PBP2 ′ monoclonal antibody is bound on the latex particles.

Results The results obtained are shown in Table 4. As shown in Table 4, it can be seen that the method according to the present invention can specifically detect the PBP2 ′ antigen of MRSA with high sensitivity as compared with Comparative Example 2.

実施例４ 比較例２
菌株１ 1:2⁹ 1:2³
菌株２ 1:2⁸ 1:2⁴
菌株３ 1:2¹¹ 1:2⁶
菌株４ 1:2⁷ 1:2²
菌株５ 1:2 ⁹ 1:2 ⁵

Example 4 Comparative Example 2
Strain 1 1: 2 ⁹ 1: 2 ³
Strain 2 1: 2 ⁸ 1: 2 ⁴
Strain 3 1: 2 ¹¹ 1: 2 ⁶
Strain 4 1: 2 ⁷ 1: 2 ²
Strain 5 1: 2 ⁹ 1: 2 ⁵

Example 5
In order to confirm the effects of the protein and the aggregation inhibitor, the following experiment was conducted.

  Normal rabbit immunoglobulin was adsorbed and bound to white latex particles (manufactured by Sekisui Chemical Co., Ltd.) with a particle size of 0.191 μm, and solutions with the following compositions were prepared, respectively, so that the concentration of latex particles was 0.1 w / v%. A normal rabbit immunoglobulin-bound latex suspension was prepared by suspending the solution in the suspension and fully suspending by sonication.

Solution composition:
Solution a: Tris base 5 mM, sodium azide 0.09 w / v%, pH 9.4
b solution: Tris base 5 mM, bovine serum albumin 0.05 w / v%, sodium azide 0.09 w / v%, pH 9.4
c solution: Tris base 5 mM, bovine serum albumin 0.05 w / v%, saccharose 15 w / v%, sodium azide 0.09 (w / v)%, pH 9.4
d solution: Tris base 5 mM, bovine serum albumin 0.05 w / v%, glycerin 15 w / v%, sodium azide 0.09 (w / v)%, pH 9.4

  The normal rabbit immunoglobulin-bound latex suspension was stored at 4 to 10 ° C., and the presence or absence of spontaneous aggregation was visually observed.

Results The results obtained are shown in Table 5. The c solution containing protein and saccharose and the d solution containing protein and glycerin did not spontaneously aggregate even when stored for 540 days, but the b solution containing only the protein containing no saccharose and glycerin did not spontaneously aggregate after storage for 360 days. Furthermore, a solution containing only Tris base containing no protein, saccharose or glycerin spontaneously aggregated in one day. From the above results, the effects of proteins and substances that prevent aggregation are clear.

保存日数
１日 ９０日 １８０日 ３６０日 ５４０日
ａ溶液 ＋ ＋ ＋ ＋ ＋
ｂ溶液 − − − ＋ ＋
ｃ溶液 − − − − −
ｄ溶液 − − − − −
−；自然凝集なし ＋；自然凝集あり

Preservation days
1 day 90 days 180 days 360 days 540 days
Solution a + + + + +
b solution − − − + +
c solution-----
d solution-----
-: No natural aggregation +: Natural aggregation

It is the top view and cut | disconnected sectional drawing of the immunochromatography apparatus which are one embodiment of this invention.

Explanation of symbols

A Membrane B Labeled part C Detection part D Sample specimen dropping part E Absorption pad part Plastic plate

Claims (12)

  Latex particles to which antibodies and / or antigen-binding fragments thereof are bound, a medium for suspending the latex particles, at least one aggregation inhibitor selected from the group consisting of saccharides and polyhydric alcohols, proteins, and buffers A latex composition for immunoassay containing an agent and having a pH of 9.0 to 9.8.   The composition according to claim 1, wherein the saccharide is at least one selected from the group consisting of monosaccharides and oligosaccharides and sugar alcohols thereof.   The composition according to claim 2, wherein the saccharide is at least one selected from the group consisting of saccharose, trehalose, maltose, lactose, sorbitol and D-mannitol.   The composition according to any one of claims 1 to 3, wherein the polyhydric alcohol is at least one selected from the group consisting of polyhydric alcohols having 2 to 10 carbon atoms.   The composition according to claim 4, wherein the polyhydric alcohol is glycerin.   The composition according to any one of claims 1 to 5, wherein the concentration of the aggregation inhibitor in the composition is 3 to 20 w / v%.   The composition according to any one of claims 1 to 6, wherein the buffer is an alkaline buffer, and the concentration in the composition is 2 to 8 mM.   The composition according to claim 7, wherein the alkaline buffer is at least one selected from the group consisting of Tris base, glycinamide and arginine.   The composition according to any one of claims 1 to 8, wherein the protein is at least one selected from the group consisting of albumin, casein, gelatin, and immunoglobulin.   The composition according to any one of claims 1 to 9, wherein a concentration of the protein in the composition is 0.02 to 0.1 w / v%.   The composition according to any one of claims 1 to 10, wherein the latex particles are colored latex particles, and the immunoassay is an immunochromatography or flow-through immunoassay. The composition according to claim 11, which is in the form of being included as a label in an immunochromatography or flow-through immunoassay device.

Images